Last week, we marked the 6 months anniversary of our official move into our new office!
Our new home is equipped with state-of-the-art meeting rooms, a lunch area, brainstorming areas, resting/mindful spaces, and an amazing lab - and we believe it will enable us to keep creating a positive work environment that our team will enjoy spending time in. đ„Œđ
At iLoF, we are passionate about improving healthcare outcomes and enabling a new future for personalized medicine - if you're interested in making a difference, do check out our website for more information about us and the career opportunities that we offer.
We are excited about this new chapter in our journey and look forward to continuing to deliver innovative solutions that improve people's lives!
#startups #awards #startup #healthcare #digitalhealth #personalizedmedicine #functionalmedicine #precisionmedicine #medicine #alzheimer #AI #photonics #computerscience #innovation #startup #office #team #environment #careeropportunities
đą WE ARE HIRING đą
We are hiring a Senior Bioclinical Lead with expertise in pre-clinical and clinical translational research, having deep understanding of natural and synthetic nanoparticles as drug delivery systems.
Apply to join our global, diverse team of scientists, inventors, and entrepreneurs with a vision of revolutionizing personalized medicine for millions of patients around the world!
Curious? Let's have a chat!
#healthcare #digitalhealth #personalizedmedicine #functionalmedicine #precisionmedicine #medicine #AI #photonics #computerscience #innovation #startup #hiring #LifeSciences #MedicalInnovation #MedicalResearch #Research #drugdelivery #nanoparticles #clinicalresearch #team
We are thrilled to announce weâve raised a $5 million funding round for our digital library of biomarkers aimed at tackling the worldâs deadliest diseases! đđ
For hundreds of years, treatments have been developed with the assumption they will work for everyone. However, each person is different, and for many severe diseases such as Alzheimerâs, multiple factors can contribute to the effectiveness of a treatment on a given patient. We are pioneering an AI platform to accelerate the future of personalized drug discovery and development. This funding will support our vision of democratizing access to personalized medicine for millions of people living with complex diseases. Our ultimate vision is to go from a next-generation bioinformatics platform to a breakthrough disease screening one. Currently, our intelligent platform is collecting massive amounts of data to build a library of biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. A big thank you to our amazing group of investors and partners: Faber, M12 - Microsoft's Venture Fund, Lunar Ventures, Alter Venture Partners, re.Mind Capital, FLUXUNIT / ams-OSRAM Ventures, Quiet Capital, Charlie Songhurst, Berggruen Holdings, EIT Health, Mayfield Fund, Faculdade de Medicina da Universidade do Porto, SaĂŻd Business School, University of Oxford And another big thank you to everyone on the iLoF team!
Find the link to read the entire news in our story!
#healthtech #investment #medtech #startupfunding #AI #ArtificialIntelligence #Photonics #AllBiomarkersHaveAFingerprint #iLoF
Last week, our team stepped away from the lab and into a different kind of âpixel space.â đź
During our team-building event, we took on a series of Pixel Arena games: an unexpectedly fitting parallel to the work we do in spectroscopy every day. What seemed like simple, fast-paced challenges quickly became a reflection of how individual signals (and people) come together to create something meaningful.
Much like in spectroscopic analysis, success in the arena required:
đč Precision in every move
đč Careful timing under pressure
đč And collaboration to turn complex signals into clear insights
A great reminder that behind every spectrum is a team working in sync, aligning small contributions into a sharper, more complete picture.
Grateful for the energy, teamwork, and a bit of healthy competition. Looking forward to bringing that same mindset back into our projects.
Meet Frank - our newest (and possibly cuter) member at iLoF.
Every day, he shows up with unmatched enthusiasm, zero complaints, and a level of focus we all aspire to, whether itâs a quick walk, a team check-in, or just brightening the office mood.
If thereâs one thing Frank reminds us, itâs this: Show up. Stay curious. Keep the energy high every day, and good things will happen (to Frank, good things mean lots of treats :)
#LifeAtILoF #OfficeVibes #TeamCulture #Motivation #WorkplaceWellbeing
Sometimes, the best ideas don't start in meetings, but around a table.
Our recent cultural lunch at iLoF brought together flavors, stories, and traditions from across our diverse team. From homemade sweets to childhood favorites, each dish carried a piece of someone's story. Moments like these remind us that behind every experiment and milestone, there's a diverse team bringing unique perspectives to the table.
Different perspectives and cultures, yet one purpose - accelerating personalized medicine.
#TeamMoments #WorkplaceCulture #iLoF #Diversity #Inclusion #LifeAtIloF #foodforthethought
Looking for a PhD opportunity that goes beyond academia?
At iLoF, weâre looking for outstanding candidates to apply for funded PhD opportunities (scholarships), opening projects in:
â Optical Instrumentation
â Clinical Assays
â Data Science
This is a chance to do doctoral research inside a deep-tech company working where photonics, clinical science and AI come together to advance personalized medicine.
If you want your PhD to combine scientific rigor, startup pace, and real-world healthcare impact, weâd love to hear from you.
Apply via www.ilof.tech/careers
And if someone in your network should see this, please share.
#DeepTech #HealthTech #Portugal
We are excited to announce a strategic collaboration with @Bluepharma , a global leader in the development and manufacturing of next-generation pharmaceutical products. The partnership includes the deployment of our AI-Powered OptomicsÂź to accelerate drug development and advance the future of personalized medicine đđ§Ș
This exciting collaboration combines iLoFâs cutting-edge technology with Bluepharmaâs expertise in pharmaceutical R&D and manufacturing, creating joint opportunities to explore, evaluate, and develop novel drugs and complex formulations. By deploying OptomicsÂź in real-world settings, both companies will assess the technology against rigorous regulatory and quality standards, from early-stage development to commercial production.
AntĂłnio Lucas Nunes, Director of Science Innovation and Strategic Partnerships at @Bluepharma , shared: âInnovation is in Bluepharmaâs DNA. Partnering with iLoF allows us to explore how advanced photonics and AI can accelerate the development of complex formulations with greater precision. This collaboration reinforces our commitment to adopting technologies that shape the future of pharmaceutical R&D.â
With operations in 40+ countries and EMA- and FDA-certified facilities, Bluepharma delivers advanced R&D, formulation development, and manufacturing services for global pharmaceutical partners, and with this strategic collaboration, both companies will push the boundaries of healthcare, with a shared vision to improve diagnostics and treatment for complex diseases.
Press release: /news-releases/ilof-and-industry-leader-bluepharma-announce-strategic-collaboration-to-deploy-ai-powered-optomics-for-faster-drug-development-and-to-advance-the-future-of-personalised-medicine-302703206.html
#PersonalizedMedicine #AI #Biotech #Pharma #DrugDevelopment #Manufacturing #R&D #DigitalHealth #Partnership
Current paradigms are built to treat diseases.
Future models will be designed to prevent themđŹ
In this episode of Innovators League, our CEO Luis Valente shares iLoFâs journey and a vision for a future of technological breakthroughs.
đïž Hear the full interview on @Expresso
https://expresso.pt/podcasts/liga-dos-inovadores/2025-12-17-hoje-em-dia-so-tomamos-medicamentos-para-corrigir-doencas.-no-futuro-vamos-toma-los-para-evita-las-as-doencas-passarao-a-ser-uma-escolha-4104558a
Bio is eating the world âĄđ§Ș
We had a blast joining the latest episode of âThe Next Big Ideaâ, a series dedicated to showcasing the big ideas and entrepreneurs transforming the world.
In an insightful conversation about how Biotechnology, Artificial Intelligence, and Deep Tech are revolutionizing healthcare, our CEO @Lu Ăs Valente shared more about how âdigital twinsâ and new patient models are enabling a revolution in clinical trials.
If youâre interested in discovering what it takes to scale bio-innovations with global impact, watch the full episode here:
/watch?v=DORwTbgGZsQ
Joao Nuncio Mondego Bio @Biovance Capital
#iLoF #TheNextBigIdea #BioTech #DigitalHealth #DeepTech #FutureOfHealthcare #Portugal
As the year comes to an end, we came together to celebrate, reflect on the journey we shared, and look ahead to the year to come đ„âš
We are grateful to everyone who supported iLoF throughout this year, your trust and commitment have been essential to our progress and achievements.
As we continue to grow, strengthening partnerships and welcoming new ones, we remain thankful to our mentors, partners, and supporters for their invaluable support.
We look forward to the new year with excitement and ambition. Wishing everyone a joyful and successful New Year! đđ